EP3665286 - CELL-FREE PROTEIN EXPRESSION USING DOUBLE-STRANDED CONCATAMERIC DNA [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 19.07.2024 Database last updated on 24.08.2024 | |
Former | The patent has been granted Status updated on 11.08.2023 | ||
Former | Grant of patent is intended Status updated on 21.05.2023 | ||
Former | Examination is in progress Status updated on 02.04.2021 | ||
Former | Request for examination was made Status updated on 15.05.2020 | ||
Former | The international publication has been made Status updated on 16.02.2019 | ||
Former | unknown Status updated on 20.08.2018 | Most recent event Tooltip | 19.07.2024 | No opposition filed within time limit | published on 21.08.2024 [2024/34] | Applicant(s) | For all designated states Global Life Sciences Solutions Operations UK Ltd 19 Jessops Riverside 800 Brightside Lane Sheffield S9 2RX / GB | [2021/21] |
Former [2020/25] | For all designated states General Electric Company 1 River Road Schenectady, NY 12345 / US | Inventor(s) | 01 /
KVAM, Erik, Leeming GE Global Research One Research Circle Niskayuna, New York 12309 / US | 02 /
NELSON, John, Richard GE Global Research One Research Circle Niskayuna, New York 12309 / US | 03 /
GAO, Wei GE Global Research One Research Circle Niskayuna, New York 12309 / US | [2020/25] | Representative(s) | Bannan, Sally Cytiva Amersham Place Little Chalfont Buckinghamshire HP7 9NA / GB | [2023/37] |
Former [2020/25] | Aldenbäck, Ulla Christina GE Healthcare Bio-Sciences AB Patent Department Björkgatan 30 751 84 Uppsala / SE | Application number, filing date | 18752135.6 | 06.08.2018 | [2020/25] | WO2018EP71229 | Priority number, date | US201715631510 | 11.08.2017 Original published format: US201715631510 | [2020/25] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019030155 | Date: | 14.02.2019 | Language: | EN | [2019/07] | Type: | A1 Application with search report | No.: | EP3665286 | Date: | 17.06.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 14.02.2019 takes the place of the publication of the European patent application. | [2020/25] | Type: | B1 Patent specification | No.: | EP3665286 | Date: | 13.09.2023 | Language: | EN | [2023/37] | Search report(s) | International search report - published on: | EP | 14.02.2019 | Classification | IPC: | C12P21/02, C12N15/67, C12P21/00 | [2023/22] | CPC: |
C12P21/02 (EP,KR,US);
C12P21/00 (US);
C12P19/34 (KR,US)
|
Former IPC [2020/25] | C12N15/67, C12P21/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/25] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | ZELLFREIE PROTEINEXPRESSION UNTER VERWENDUNG VON DOPPELSTRÄNGIGER KONKATAMER-DNA | [2020/25] | English: | CELL-FREE PROTEIN EXPRESSION USING DOUBLE-STRANDED CONCATAMERIC DNA | [2020/25] | French: | EXPRESSION ACELLULAIRE DE PROTÉINES À L'AIDE D'ADN CONCATÉMÈRE À DOUBLE BRIN | [2020/25] | Entry into regional phase | 16.01.2020 | National basic fee paid | 16.01.2020 | Designation fee(s) paid | 16.01.2020 | Examination fee paid | Examination procedure | 16.01.2020 | Examination requested [2020/25] | 16.01.2020 | Date on which the examining division has become responsible | 22.09.2020 | Amendment by applicant (claims and/or description) | 01.04.2021 | Despatch of a communication from the examining division (Time limit: M06) | 05.10.2021 | Reply to a communication from the examining division | 22.05.2023 | Communication of intention to grant the patent | 07.08.2023 | Fee for grant paid | 07.08.2023 | Fee for publishing/printing paid | 07.08.2023 | Receipt of the translation of the claim(s) | Opposition(s) | 14.06.2024 | No opposition filed within time limit [2024/34] | Fees paid | Renewal fee | 19.08.2020 | Renewal fee patent year 03 | 13.08.2021 | Renewal fee patent year 04 | 15.06.2022 | Renewal fee patent year 05 | 14.06.2023 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 13.09.2023 | CZ | 13.09.2023 | DK | 13.09.2023 | EE | 13.09.2023 | FI | 13.09.2023 | HR | 13.09.2023 | LT | 13.09.2023 | LV | 13.09.2023 | PL | 13.09.2023 | RO | 13.09.2023 | RS | 13.09.2023 | SK | 13.09.2023 | SM | 13.09.2023 | NO | 13.12.2023 | GR | 14.12.2023 | IS | 13.01.2024 | PT | 15.01.2024 | [2024/33] |
Former [2024/25] | AT | 13.09.2023 | |
CZ | 13.09.2023 | ||
EE | 13.09.2023 | ||
FI | 13.09.2023 | ||
HR | 13.09.2023 | ||
LT | 13.09.2023 | ||
LV | 13.09.2023 | ||
PL | 13.09.2023 | ||
RO | 13.09.2023 | ||
RS | 13.09.2023 | ||
SK | 13.09.2023 | ||
SM | 13.09.2023 | ||
NO | 13.12.2023 | ||
GR | 14.12.2023 | ||
IS | 13.01.2024 | ||
PT | 15.01.2024 | ||
Former [2024/23] | AT | 13.09.2023 | |
CZ | 13.09.2023 | ||
EE | 13.09.2023 | ||
FI | 13.09.2023 | ||
HR | 13.09.2023 | ||
LT | 13.09.2023 | ||
LV | 13.09.2023 | ||
RO | 13.09.2023 | ||
RS | 13.09.2023 | ||
SK | 13.09.2023 | ||
SM | 13.09.2023 | ||
NO | 13.12.2023 | ||
GR | 14.12.2023 | ||
IS | 13.01.2024 | ||
PT | 15.01.2024 | ||
Former [2024/20] | FI | 13.09.2023 | |
HR | 13.09.2023 | ||
LT | 13.09.2023 | ||
LV | 13.09.2023 | ||
RS | 13.09.2023 | ||
SM | 13.09.2023 | ||
NO | 13.12.2023 | ||
GR | 14.12.2023 | ||
IS | 13.01.2024 | ||
Former [2024/11] | FI | 13.09.2023 | |
HR | 13.09.2023 | ||
LT | 13.09.2023 | ||
LV | 13.09.2023 | ||
RS | 13.09.2023 | ||
NO | 13.12.2023 | ||
GR | 14.12.2023 | ||
Former [2024/09] | FI | 13.09.2023 | |
LT | 13.09.2023 | ||
NO | 13.12.2023 | ||
GR | 14.12.2023 | ||
Former [2024/08] | LT | 13.09.2023 | |
NO | 13.12.2023 | ||
GR | 14.12.2023 | Cited in | International search | [YP]WO2017191007 (GEN ELECTRIC [US], et al) [YP] 13-27 * Whole document, especially example 3 and the claims. *; | [YA] - NAOKO ABE ET AL, "Rolling Circle Translation of Circular RNA in Living Human Cells", SCIENTIFIC REPORTS, (20151110), vol. 5, no. 1, doi:10.1038/srep16435, XP055511341 [Y] 13-27 * the whole document * [A] 1-12 DOI: http://dx.doi.org/10.1038/srep16435 | [A] - GYANENDRA KUMAR ET AL, "Cell-free protein synthesis using multiply-primed rolling circle amplification products", BIOTECHNIQUES RAPID DISPATCHES, US, (20090701), vol. 47, no. 1, doi:10.2144/000113171, ISSN 0736-6205, pages 637 - 639, XP055380979 [A] 1-27 * the whole document * DOI: http://dx.doi.org/10.2144/000113171 | [A] - JUN LI ET AL, "Improved Cell-Free RNA and Protein Synthesis System", PLOS ONE, (20140902), vol. 9, no. 9, doi:10.1371/journal.pone.0106232, page e106232, XP055377617 [A] 1-27 * abstract * DOI: http://dx.doi.org/10.1371/journal.pone.0106232 | [A] - GAGOSKI DEJAN ET AL, "Gateway-compatible vectors for high-throughput protein expression in pro- and eukaryotic cell-free systems", JOURNAL OF BIOTECHNOLOGY, ELSEVIER, AMSTERDAM, NL, (20141219), vol. 195, doi:10.1016/J.JBIOTEC.2014.12.006, ISSN 0168-1656, pages 1 - 7, XP029221969 [A] 1-27 * abstract * DOI: http://dx.doi.org/10.1016/j.jbiotec.2014.12.006 | by applicant | - SINGH, S. K., Chem. Comm., (19980000), vol. 4, pages 455 - 456 | - KOSHKIN, A. A., Tetrahedron, (19980000), vol. 54, pages 3607 - 3630 |